Literature DB >> 11480310

Viable M. leprae as a research reagent.

R W Truman1, J L Krahenbuhl.   

Abstract

Mycobacterium leprae remain a rare research resource. They cannot be cultivated on artificial media, and the only established means to quantify viability of M. leprae has been by its relative growth in the foot pads of conventional mice (MFP). The MFP method is technically difficult and requires several months to yield results. More effective methods are needed. We examined the association between M. leprae's ability to oxidize 14C-palmitate in axenic culture and the MFP growth results of a large number of suspensions. Oxidative activity was assessed by radiorespirometry (RR) using the Buddemeyer-type biphasic culture vessels containing 7H12 liquid medium and 14C-palmitate, or with commercially prepared BACTEC 12B vessels containing the same medium. The RR results were highly correlated (r = 0.71) with the growth level that each M. leprae suspension achieved by the MFP technique. In using this technique to examine the effects that many common laboratory practices have on M. leprae viability, we found that viability varies markedly between bacillary suspensions derived from different hosts and tissues. The highest viabilities were obtained with bacilli from moderately enlarged nude MFP (< 1 g). Viability tended to be lower among very large nude MFP or long-duration infections and from armadillo tissues. After their harvest from host tissues, leprosy bacilli lost viability quickly. Suspensions stored in 7H12 liquid medium retained < 1% of their viability within 3 weeks of harvest, and freezing bacillary preparations or incubating them at 37 degrees C resulted in nearly an immediate equivalent loss in metabolic activity and viability. M. leprae viability is maintained best when bacilli are stored for only short periods of time at 4 degrees C-33 degrees C. Palmitate oxidation is a rapid, reliable and objective means by which to estimate the viability of M. leprae and can be used effectively as a surrogate for the conventional MFP technique in many studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11480310

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  56 in total

1.  Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection.

Authors:  Annemieke Geluk; Michèl R Klein; Kees L M C Franken; Krista E van Meijgaarden; Brigitte Wieles; Kelly Cristina Pereira; Samira Bührer-Sékula; Paul R Klatser; Patrick J Brennan; John S Spencer; Diana L Williams; Maria C V Pessolani; Elizabeth P Sampaio; Tom H M Ottenhoff
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli.

Authors:  Nikos Tapinos; Anura Rambukkana
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

3.  Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.

Authors:  Malcolm S Duthie; Rhea N Coler; John D Laurance; Lucas H Sampaio; Regiane M Oliveira; Ana Lucia M Sousa; Mariane M A Stefani; Yumi Maeda; Masanori Matsuoka; Masahiko Makino; Steven G Reed
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

4.  Modulation of the cytokine response in human monocytes by mycobacterium leprae phenolic glycolipid-1.

Authors:  Claudia Manca; Blas Peixoto; Wladimir Malaga; Christophe Guilhot; Gilla Kaplan
Journal:  J Interferon Cytokine Res       Date:  2011-10-07       Impact factor: 2.607

Review 5.  The armadillo as a model for peripheral neuropathy in leprosy.

Authors:  Richard W Truman; Gigi J Ebenezer; Maria T Pena; Rahul Sharma; Gayathriy Balamayooran; Thomas H Gillingwater; David M Scollard; Justin C McArthur; Anura Rambukkana
Journal:  ILAR J       Date:  2014

6.  Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillos.

Authors:  Malcolm S Duthie; Richard W Truman; Wakako Goto; Joanne O'Donnell; Marah N Hay; John S Spencer; Darrick Carter; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

7.  Multiple polymorphic loci for molecular typing of strains of Mycobacterium leprae.

Authors:  Nathan A Groathouse; Becky Rivoire; Hansuk Kim; Hyeyoung Lee; Sang-Nae Cho; Patrick J Brennan; Varalakshmi D Vissa
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Validation of qPCR Methods for the Detection of Mycobacterium in New World Animal Reservoirs.

Authors:  Genevieve Housman; Joanna Malukiewicz; Vanner Boere; Adriana D Grativol; Luiz Cezar M Pereira; Ita de Oliveira Silva; Carlos R Ruiz-Miranda; Richard Truman; Anne C Stone
Journal:  PLoS Negl Trop Dis       Date:  2015-11-16

9.  Antigen-specific T-cell responses of leprosy patients.

Authors:  Malcolm S Duthie; Wakako Goto; Greg C Ireton; Stephen T Reece; Lucas H Sampaio; A B Grassi; Ana Lucia M Sousa; Celina M T Martelli; Mariane M A Stefani; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2008-09-10

10.  Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection.

Authors:  Toshihiro Masaki; Jinrong Qu; Justyna Cholewa-Waclaw; Karen Burr; Ryan Raaum; Anura Rambukkana
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.